These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 16956910)
1. Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes. Perrella G; Brusini P; Spelat R; Hossain P; Hopkinson A; Dua HS Br J Ophthalmol; 2007 Jan; 91(1):94-9. PubMed ID: 16956910 [TBL] [Abstract][Full Text] [Related]
2. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells. Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674 [TBL] [Abstract][Full Text] [Related]
3. [Expression of AC133 vs. CD34 in acute childhood leukemias]. Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777 [TBL] [Abstract][Full Text] [Related]
4. A novel population of repair cells identified in the stroma of the human cornea. Thill M; Schlagner K; Altenähr S; Ergün S; Faragher RG; Kilic N; Bednarz J; Vohwinkel G; Rogiers X; Hossfeld DK; Richard G; Gehling UM Stem Cells Dev; 2007 Oct; 16(5):733-45. PubMed ID: 17999595 [TBL] [Abstract][Full Text] [Related]
5. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture]. Hao SG; Sun GL; Wu WL; Wu YL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136 [TBL] [Abstract][Full Text] [Related]
6. Mobilization of human CD34+ CD133+ and CD34+ CD133(-) stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae--related to modulation of CXCR4 expression by an L-selectin ligand? Jensen GS; Hart AN; Zaske LA; Drapeau C; Gupta N; Schaeffer DJ; Cruickshank JA Cardiovasc Revasc Med; 2007; 8(3):189-202. PubMed ID: 17765649 [TBL] [Abstract][Full Text] [Related]
7. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells. Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669 [TBL] [Abstract][Full Text] [Related]
9. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation. Hicks C; Wong R; Manoharan A; Kwan YL Ann Hematol; 2007 Aug; 86(8):591-8. PubMed ID: 17492259 [TBL] [Abstract][Full Text] [Related]
10. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood. Lazarova P; Wu Q; Kvalheim G; Suo Z; Haakenstad KW; Metodiev K; Nesland JM Int J Immunopathol Pharmacol; 2006; 19(1):49-56. PubMed ID: 16569339 [TBL] [Abstract][Full Text] [Related]
11. Increased levels of NOTCH1, NF-kappaB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells. Panepucci RA; Oliveira LH; Zanette DL; Viu Carrara Rde C; Araujo AG; Orellana MD; Bonini de Palma PV; Menezes CC; Covas DT; Zago MA Stem Cells Dev; 2010 Mar; 19(3):321-32. PubMed ID: 19686049 [TBL] [Abstract][Full Text] [Related]
12. CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers. Sosnová M; Bradl M; Forrester JV Stem Cells; 2005 Apr; 23(4):507-15. PubMed ID: 15790772 [TBL] [Abstract][Full Text] [Related]
13. Platelet released growth factors boost expansion of bone marrow derived CD34(+) and CD133(+) endothelial progenitor cells for autologous grafting. Lippross S; Loibl M; Hoppe S; Meury T; Benneker L; Alini M; Verrier S Platelets; 2011; 22(6):422-32. PubMed ID: 21473675 [TBL] [Abstract][Full Text] [Related]
14. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients. Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576 [TBL] [Abstract][Full Text] [Related]
15. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein. Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897 [TBL] [Abstract][Full Text] [Related]
16. Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Schwab KE; Hutchinson P; Gargett CE Hum Reprod; 2008 Apr; 23(4):934-43. PubMed ID: 18305000 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells. Hemmoranta H; Hautaniemi S; Niemi J; Nicorici D; Laine J; Yli-Harja O; Partanen J; Jaatinen T Stem Cells Dev; 2006 Dec; 15(6):839-51. PubMed ID: 17253947 [TBL] [Abstract][Full Text] [Related]
18. Erythropoiesis from adult but not fetal blood-derived CD133+ stem cells depends strongly on interleukin-3. Böhmer RM Growth Factors; 2004 Mar; 22(1):45-50. PubMed ID: 15176458 [TBL] [Abstract][Full Text] [Related]
19. Generation of CD133+ cells from CD133- peripheral blood mononuclear cells and their properties. Suuronen EJ; Wong S; Kapila V; Waghray G; Whitman SC; Mesana TG; Ruel M Cardiovasc Res; 2006 Apr; 70(1):126-35. PubMed ID: 16530743 [TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor. Freund D; Oswald J; Feldmann S; Ehninger G; Corbeil D; Bornhäuser M Cell Prolif; 2006 Aug; 39(4):325-32. PubMed ID: 16872366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]